HPS Pharmacies wish to advise that Sandoz is experiencing a supply interruption for Ziextenzo® pre-filled syringes, as follows:
Ziextenzo®
Pegfilgrastim 6mg/0.6mL
ARTG 308367
This supply interruption is expected to begin in mid-October and continue until the end of November 2026. However, stock has already been depleted in some states.
The biosimilar, Pelgraz®, is not affected by this notice. Prescribers may also wish to consider therapeutic alternatives, where appropriate. Lipegfilgrastim (Lonquex®) is currently readily available.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Sandoz on 1800 726 369, or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates
